Chenguang Biotech Group (300138) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.07x

Chenguang Biotech Group (300138) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥37.63 Million (capex CN¥37.63 Million ) from operating cash flow of CN¥524.96 Million. See how much free cash does Chenguang Biotech Group generate to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.07x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥37.63 Million
Capex + Investments

Operating Cash Flow

CN¥524.96 Million
CNY

Capital Expenditures

CN¥37.63 Million
CNY

Chenguang Biotech Group Cash Flow Reinvestment Rate (2008–2022)

Historical reinvestment intensity for Chenguang Biotech Group across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Chenguang Biotech Group.

Annual Cash Flow Reinvestment Rate for Chenguang Biotech Group (2008–2022)

Year-by-year capital reinvestment analysis for Chenguang Biotech Group. See Chenguang Biotech Group (300138) flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2022 0.98x CN¥716.94 Million CN¥734.81 Million CN¥176.03 Million ▼ -92.4%
2021 12.86x CN¥821.73 Million CN¥63.90 Million CN¥280.82 Million ▲ +1423.3%
2020 0.84x CN¥446.93 Million CN¥529.41 Million CN¥436.88 Million ▲ +529.2%
2014 0.13x CN¥36.62 Million CN¥272.96 Million CN¥36.62 Million ▼ -93.9%
2011 2.21x CN¥181.72 Million CN¥82.18 Million CN¥181.72 Million ▼ -10.0%
2009 2.46x CN¥66.90 Million CN¥27.23 Million CN¥66.90 Million ▼ -14.5%
2008 2.87x CN¥26.05 Million CN¥9.06 Million CN¥26.05 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow